Mimetogen Pharmaceuticals
Latest round
- Series B
Last raised
- Oct 2011
Total raised
- $2.9M
Investors
- 4
About Mimetogen Pharmaceuticals
Mimetogen Pharmaceuticals Inc.Founded in 2004 and headquartered in Montreal, Canada, Mimetogen Pharmaceuticals Inc. specializes in creating innovative treatments for ocular surface diseases. The company's lead product, tavilermide, is undergoing multi-center Phase 3 clinical trials.Mimetogen Pharmaceuticals specializes in the development of synthetic neurotrophin mimetics, focusing on tavilermide (formerly MIM-D3), which aims to treat dry eye disease (DED). This product targets significant unmet medical needs and is currently evaluated in Phase 3 clinical studies in the United States.Mimetogen Pharmaceuticals operates under a clinical development framework, generating revenue through partnerships and collaborations in the biopharmaceutical sector. Their revenue model includes clinical trial agreements and licensing arrangements, which may involve milestone payments as tavilermide progresses through clinical phases and potentially reaches market approval. The company is also exploring expansion into additional geographic regions, with a particular focus on increasing its presence in North America and potentially international markets following successful clinical outcomes.
Who invested in Mimetogen Pharmaceuticals
4 investors across 4 rounds
See all investors in Mimetogen Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mimetogen Pharmaceuticals
Who invested in Mimetogen Pharmaceuticals?
Mimetogen Pharmaceuticals has 4 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mimetogen Pharmaceuticals raised?
Mimetogen Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Mimetogen Pharmaceuticals last raise money?
Mimetogen Pharmaceuticals's most recent round on record is a Series B, in Oct 2011.
What does Mimetogen Pharmaceuticals do?
Mimetogen Pharmaceuticals is a biotechnology company.
Where is Mimetogen Pharmaceuticals headquartered?
Mimetogen Pharmaceuticals is headquartered in Montreal, Canada.
Which VCs invest in companies like Mimetogen Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mimetogen Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Mimetogen Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.